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A B S T R A C T
Dihydrochalcones are plant secondary metabolites comprising molecules of signiﬁcant commercial interest as
antioxidants, antidiabetics, or sweeteners. To date, their heterologous biosynthesis in microorganisms has been
achieved only by precursor feeding or as minor by-products in strains engineered for ﬂavonoid production.
Here, the native ScTSC13 was overexpressed in Saccharomyces cerevisiae to increase its side activity in
reducing p-coumaroyl-CoA to p-dihydrocoumaroyl-CoA. De novo production of phloretin, the ﬁrst committed
dihydrochalcone, was achieved by co-expression of additional relevant pathway enzymes. Naringenin, a major
by-product of the initial pathway, was practically eliminated by using a chalcone synthase from barley with
unexpected substrate speciﬁcity. By further extension of the pathway from phloretin with decorating enzymes
with known speciﬁcities for dihydrochalcones, and by exploiting substrate ﬂexibility of enzymes involved in
ﬂavonoid biosynthesis, de novo production of the antioxidant molecule nothofagin, the antidiabetic molecule
phlorizin, the sweet molecule naringin dihydrochalcone, and 3-hydroxyphloretin was achieved.
1. Introduction
Since phlorizin was identiﬁed in apples as the ﬁrst dihydrochalcone
(DHC) in 1835 (Petersen, 1835), there has been signiﬁcant interest in
this class of compounds, accompanied by scientiﬁc research into their
potential beneﬁts for humans. While DHCs have long been thought to
be restricted to plants belonging to about 30 plant families (Ninomiya
and Koketsu, 2013), DHCs were more recently found in signiﬁcant
amounts in grapes and raspberries, and with the development of novel
and more sensitive analytical methods it is becoming obvious that they
might be more widespread (Carvalho et al., 2013; Vrhovsek et al.,
2012). Apples however remain unique in that they accumulate DHCs to
very high concentrations of up to 14% dry weight in leaves (Gosch
et al., 2010b). Although knowledge about the functional role of DHCs
in planta is limited, many of these structures have received attention
for other reasons, mostly relating to a variety of human health and food
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applications (Rozmer and Perjési, 2016). Three of the most prominent
examples of active DHCs described in literature are brieﬂy outlined
here. Phlorizin was found to be a hypoglycemic agent, acting by
inhibiting SGLT1 and SGLT2, the human glucose transporters involved
in intestinal glucose absorption and renal glucose reabsorption
(Ehrenkranz et al., 2005). It was later used as a blueprint for the
development of over ten synthetic antidiabetic drugs (Chao, 2014),
three of which have been approved by the Food and Drug
Administration (FDA) and European Medicine Agency (EMA)
(Scheen, 2015). Aspalathin and nothofagin, which are naturally found
in rooibos (Aspalathus linearis), exhibit strong antioxidant activity
(Snijman et al., 2009) and are absorbed by the human body as intact
glycosides due to the metabolic stability of their C-C-glycosidic bond
(Breiter et al., 2011). Naringin dihydrochalcone (NDC) and neohesper-
idin dihydrochalcone (NHDC), which can be chemically synthesized
from citrus ﬂavanones, are sweeteners with one and twenty times the
sweetness of saccharin on a molar basis, respectively (Horowitz and
Gentili, 1969) with NHDC approved as the food additive E959 in
Europe (Janvier et al., 2015).
Chemically, the DHCs comprise a 1,3-diphenylpropan-1-one ske-
leton. They are further functionalized, mainly on the two aromatic
rings, by hydroxylation, methylation, prenylation, glycosylation, and/or
polymerization. Just over 200 structurally diﬀerent DHCs have been
identiﬁed to date (Rozmer and Perjési, 2016). Their proposed bio-
synthesis in plants is depicted in Fig. 1. The early pathway from
phenylalanine to p-coumaroyl-CoA is catalysed by phenylalanine
ammonia lyase (PAL), cinnamate 4-hydroxylase (C4H), and 4-couma-
rate-CoA ligase (4CL). These steps are shared with the biosynthesis of
lignans and other polyketides, such as ﬂavonoids or stilbenoids, and
have been thoroughly studied and characterized (Gosch et al., 2010b).
The action of a double bond reductase (DBR) to form p-dihydrocou-
maroyl-CoA from p-coumaroyl-CoA appears to be required to initiate
the biosynthesis of DHCs (Dare et al., 2013a; Gosch et al., 2009). Three
diﬀerent enzymes from apple (Malus x domestica) have recently been
suggested to catalyse this reaction in planta (Dare et al., 2013a; Ibdah
et al., 2014). Phloretin, the ﬁrst committed DHC, is then formed by
decarboxylative condensation with three units of malonyl-CoA and a
subsequent cyclisation, all catalysed by chalcone synthase (CHS). CHS
was found to be shared between the ﬂavonoid and DHC pathways in
apple (Gosch et al., 2009). Except for a few UDP-dependent-glycosyl-
transferases (UGTs) from apple, pear, and carnation which can
glycosylate the 2′-hydroxygroup of phloretin to form phlorizin (Gosch
et al., 2010a; Jugdé et al., 2008; Werner and Morgan, 2009), and two
UGTs from rice and buckwheat which are able to C-glycosylate the 3′-
position to form nothofagin (Brazier-Hicks et al., 2009; Ito et al.,
2014), plant enzymes for further decoration of DHCs still remain to be
identiﬁed (Fig. 1B). During the preparation of this manuscript, a study
was published, reporting that chalcone 3-hydroxylase (CH3H) from
Cosmos sulphureus can hydroxylate phloretin to form 3-hydroxyphlor-
etin in yeast and in plants (Hutabarat et al., 2016). During the revision
of this manuscript, an additional study was published, reporting that
MdPh-4′-OGT from Malus×domestica can glycosylate the 4′-hydro-
xygroup of phloretin to form trilobatin (Yahyaa et al., 2016).
Since the early 2000s, technologies arising from systems and
synthetic biology have revolutionized metabolic engineering (Xu
et al., 2013). Besides academic studies showing the production of
Fig. 1. (A) The biosynthetic pathway to the ﬁrst committed DHC (phloretin), ﬂavonoid (naringenin), and stilbenoid (resveratrol) from phenylalanine and malonyl-CoA is shown. (B)
Depicted are proposed biosynthetic routes to several hydroxylated, glycosylated, and methylated DHC derivatives. CHI, chalcone isomerase; CHS, chalcone synthase; CPR, cytochrome
P450 reductase; CYP, cytochrome P450; C4H, cinnamate 4-hydroxylase; DBR, double bond reductase; OMT, O-methyltransferase; PAL, phenylalanine ammonia lyase; STS, stilbene
synthase; UGT, UDP-dependent-glycosyltransferase; 4CL, 4-coumarate-CoA ligase.
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numerous compounds in microbial hosts, these developments have
resulted in commercialization of biological processes for heterologous
production of at least 20 products in the ﬁelds of bulk chemicals (e.g.
2,4-butanediol, farnesene), pharmaceutical compounds (e.g. artemisi-
nin), fragrances (e.g. nootkatone), food chemicals (e.g. resveratrol,
vanillin), and biofuels (e.g. isobutanol, ethanol) (Jullesson et al., 2015).
In comparison to extraction from plant materials, such biotechnologi-
cal processes allow eﬃcient production of speciﬁc compounds in an
environmentally sustainable way, avoiding the supply chain problems
arising from the dependency on plant growth (Krivoruchko and
Nielsen, 2015).
Flavonoids and stilbenoids have both been very popular targets in
many metabolic engineering publications and two recent reviews give a
good overview of the ﬁeld (Pandey et al., 2016; Wang et al., 2016). On
the other hand, DHCs have been the subject of only three studies. Two
of these studies (Watts et al., 2004; Werner et al., 2010) expressed 4CL
and CHS enzymes in Escherichia coli and Saccharomyces cerevisiae,
respectively, and produced phloretin by feeding phloretic acid. This
strategy circumvents the critical DBR step needed to generate the
starter molecule for DHC biosynthesis. In another study, a CHI and an
enoate reductase from Eubacterium ramulus was expressed in E. coli
and the compounds phloretin, 3-hydroxyphloretin, and homoeriodic-
tyol DHC were produced by feeding naringenin, eriodictyol, and
homoeriodictyol, respectively (Gall et al., 2014). However, besides
the high cost of these precursors, this strategy additionally required
anaerobic cultivation to achieve suﬃcient enzymatic activity.
In this study we demonstrated the utility of S. cerevisiae as
microbial cell factory by showing, as a proof of concept, the de novo
production of various DHCs of commercial interest. A side activity of
the native ScTsc13 to reduce p-coumaroyl-CoA was used for construct-
ing a biosynthetic pathway to phloretin. Naringenin as a major by-
product was substantially decreased by using a highly selective barley
CHS for the last step of the pathway. The phloretin pathway was then
extended to produce several decorated DHCs using previously identi-
ﬁed enzymes, some of which were shown to exhibit suﬃcient substrate
ﬂexibility outside their normal functions in ﬂavonoid biosynthesis.
2. Materials and methods
2.1. Chemicals
Unless stated otherwise, chemicals were purchased from Sigma-
Aldrich (St. Louis, Missouri, USA). Authentic standards of cinnamic
acid, p-coumaric acid, naringenin, NDC, pinocembrin, phloretic acid,
and phlorizin were purchased from Sigma-Aldrich. Authentic stan-
dards of phloretin and trilobatin were purchased from Extrasynthese
(Genay Cedex, France). Authentic standards of 3-hydroxyphloretin and
pinocembrin DHC were purchased from PlantMetaChem (Giessen,
Germany) and AnalytiCon (Potsdam, Germany), respectively.
Nothofagin was kindly provided by Dr. Alexander Gutmann (Graz
University, Austria).
2.2. Strains, plasmids, and media
E. coli XL10 Gold (Agilent, Santa Clara, California, USA) cells were
used for subcloning of genes. Table 1 lists all plasmids constructed in
this work. Coding sequences for selected enzymes were cloned into
expression cassettes of plasmids pEVE2176 to pEVE2181 for assembly
by in vivo homologous recombination (see Section 2.4). Generally,
cloning was done by restriction enzyme and ligation based cloning with
HindIII HF, SacII, and T4 DNA ligase (all New England Biolabs,
Ipswich, Massachusetts, USA) according to standard protocols (Green
and Sambrook, 2012). Genes containing internal HindIII or SacII sites
were cloned by In-Fusion (Takara, Kyoto, Japan) according to the
manufacturer's instructions. E. coli was grown in LB medium prepared
with 25 g/l of LB broth (Miller) and supplemented with 100 μg/l
ampicillin for ampliﬁcation of plasmids.
S. cerevisiae strain BG (MATα hoΔ0 his3Δ0 leu2Δ0 ura3Δ0
cat5Δ0::CAT5(I91M) mip1Δ0::MIP1(A661T) gal2Δ0::GAL2
sal1Δ0::SAL1), which is a derivative of the S288C strain NCYC 3608
(NCYC, Norwich, United Kingdom), was used for all experiments in
this work. The strain had been further modiﬁed in our labs. Brieﬂy, the
LEU2 and HIS3 open reading frames were deleted to create two
additional auxotrophies for leucine and histidine, respectively. The
KanMX cassette was excised by Cre-Lox recombination. The non-
functional gal2 gene was replaced with a functional allele from S.
cerevisiae SK1 strain NCYC 3615 (NCYC) and the sal1,mip1, and cat5
genes were engineered to reduce petite formation (Dimitrov et al.,
2009). Yeast cultures were grown in SC medium prepared with 1.47 g/l
Synthetic Complete (Kaiser) Drop Out: Leu, His, Ura (Formedium,
Hunstanton, United Kingdom), 6.7 g/l Yeast Nitrogen Base Without
Amino Acids, 20 g/l D-(+)-Glucose, pH set to 5.8 with hydrochloric
acid, and supplemented with 76 mg/l histidine, 380 mg/l leucine, and/
or 76 mg/l uracil depending on the plasmids to be maintained in the
strains.
2.3. Genes
Table 1 shows all genes used in this study, as well as the vector
backbones they were cloned into. Coding sequences of all genes can be
found in Supplementary Table 4. S. cerevisiae codon optimized genes
were manufactured by GeneArt (ThermoFisher, Waltham,
Massachusetts, USA), except genes in pDHC25 and pDHC26, which
were obtained by site directed mutagenesis of pDHC24 using overlap
extension PCR with primers DHPR1 to DHPR10 (Supplementary
Table 1) according to a standard protocol (Heckman and Pease,
2007). During synthesis or PCR, all genes were provided at the 5′
end with an AAGCTTAAA DNA sequence comprising aHindIII site and
a Kozak sequence and at the 3′ end a GGCGCC DNA sequence
comprising a SacII restriction site. Genes in pDHC3, pDHC6, and
pDHC7 were ampliﬁed by PCR (Q5 DNA polymerase, New England
Biolabs) with primers DHPR11 to DHPR16 (Supplementary Table 1)
from a colony of S. cerevisiae S288C after lysis in 30 μl 0.2% SDS at
95 °C for 5 min and clariﬁcation at 14,000g for 5 min. For the genes in
pDHC7 and pDHC8, restriction sites and Kozak sequence, as described
above, were added during PCR. ScCPR1 in pDHC3 was initially cloned
with SpeI and XhoI, because it contained an internal SacII site. This
site was then removed with a silent mutation (c519t) introduced by
inverse PCR using primers DHPR17 and DHPR18 according to
standard protocols (Green and Sambrook, 2012). For genes in
pDHC4, pDHC22, pDHC23, pDHC30, pDHC31, pDHC33, pDHC38,
and pDHC39, RNA was extracted from Arabidopsis thaliana leaves or
M. x domestica var. Golden Delicious apple peel with the RNeasy kit
(Qiagen, Venlo, Netherlands) according to the manufacturer's instruc-
tions. First strand cDNA was synthesized with the Mint-2 cDNA
synthesis kit (Evrogen, Moscow, Russia) and genes were ampliﬁed by
PCR (Q5 DNA polymerase) with primers DHPR19 to DHPR34
(Supplementary Table 1). During PCR, an AAA Kozak sequence was
added to the 5′ end of the gene and 15 base pairs with homology to the
plasmid backbone were added at the 5′ and 3′ end of the gene for
cloning by In-Fusion into plasmid backbones linearized with HindIII
and SacII.
2.4. Assembly of multi-expression plasmids by homologous
recombination tags (HRTs)
Multiple expression cassettes were assembled into multi-expression
plasmids with an in vivo homologous recombination technique slightly
modiﬁed from DNA assembler (Shao et al., 2009). In contrast to the
original version, the 60 base pair homology sequences used to assemble
diﬀerent cassettes were not added by PCR but were already present in
HRT entry vectors. This allows indeﬁnite reuse of cassettes after initial
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cloning and sequence veriﬁcation of the respective genes. After cloning
into these entry vectors, both expression cassettes and helper frag-
ments required for assembly of HRT plasmids are ﬂanked by 60 base
pair HRTs named A, B, C, D, E, F, G, H, and Z, which are in turn
ﬂanked by AscI restriction sites for release of the tagged fragments.
Supplementary Table 2 lists all basic parts used in this work. Genes of
interest were cloned into pEVE2176-2181 as shown in Table 1. For
multi-expression HRT plasmid assembly 310 fmol each of the ZA and
AB entry plasmids, containing all elements required for replication,
maintenance, and selection, were combined with 460 fmol each of all
other entry plasmids, containing the expression cassettes and the
closing linker. The complete mixture was digested with AscI (New
England Biolabs) in a 10 μl reaction, releasing all inserts from their
vector backbone, followed by heat inactivation of the restriction
enzyme at 80 °C for 20 min. The whole reaction was used to transform
S. cerevisiae with a standard LiAc transformation (Gietz and Schiestl,
2007). Supplementary Table 3 lists all strains constructed in this work.
2.5. Yeast growth and broth extraction
Yeast batch cultures for production of metabolites were performed
with the System Duetz (EnzyScreen, Heemstede, Netherlands). All
incubation steps for growth and extraction were performed in an ISF-
1-W shaker (Kuhner, Birsfelden, Switzerland) at 30 °C, 300 RPM, and
5 cm shaking diameter. Precultures were inoculated in a square 96-
half-deepwell microplate from a single colony in three replicates in
300 μl SC dropout medium, as required for plasmid selection, and
incubated for 24 h. Optical density at 600 nm (OD600) of a 1:50
dilution was measured in an Ultrospec 10 table top spectrophotometer
(GE Healthcare, Little Chalfont, United Kingdom). Main cultures were
inoculated in 2 ml of the same SC medium in a 24-deepwell microplate
to an OD600 of 0.1 and incubated for 72 h. Final OD600 of a 1:50
dilution was measured and 300 μl broth was extracted with 300 μl
methanol by incubating for 10 min in a 96 square deepwell microplate
and ﬁnally clariﬁed by centrifugation at 4000g for 5 min.
2.6. Quantiﬁcation of compounds by UPLC-MS
Clariﬁed broth extracts were diluted four times with 50% methanol
and 2 μl was injected on a Waters Acquity ultra performance liquid
chromatography system coupled to a Waters Acquity triple quadrupole
mass detector (Milford, Massachusetts, USA). Separation of the
compounds was achieved on a Waters Acquity UPLC® BEH C18
column (1.7 µm, 2.1 mm×50 mm) kept at 55 °C. Mobile phases A
and B were water containing 0.1% formic acid and acetonitrile
containing 0.1% formic acid, respectively. A ﬂow of 0.6 ml/min was
used. The gradient proﬁle was as follow: 0.3 min constant at 10% B, a
linear gradient from 10% B to 25% B in 3.7 min, a second linear
gradient from 25% B to 100% B in 1 min, a wash for 1 min at 100% B,
and back to the initial condition of 10% B for 0.6 min. The mass
Table 1
List of genes used in this work and HRT backbones they were cloned into.
Plasmid name Gene Backbone Codon optimized Organism NCBI protein accession
pDHC1 AtPAL2 pEVE2179 yes Arabidopsis thaliana NP_190894.1
pDHC2 AmC4H pEVE2180 yes Ammi majus AAO62904.1
pDHC3 ScCPR1 pEVE2181 no Saccharomyces cerevisiae NP_011908.1
pDHC4 At4CL2 pEVE2178 no Arabidopsis thaliana NP_188761.1
pDHC5 HaCHS pEVE2176 yes Hypericum androsaemum Q9FUB7.1
pDHC6 ScDFG10 pEVE2177 no Saccharomyces cerevisiae NP_012215.1
pDHC7 ScTSC13 pEVE2177 no Saccharomyces cerevisiae NP_010269.1
pDHC8 KlTSC13 pEVE2177 yes Kluyveromyces lactis XP_452392.1
pDHC9 AtECR pEVE2177 yes Arabidopsis thaliana NP_191096.1
pDHC10 GhECR2 pEVE2177 yes Gossypium hirsutum NP_001314306.1
pDHC11 MdECR pEVE2177 yes Malus x domestica XP_008382818.1
pDHC12 MdENRL3 pEVE2177 yes Malus x domestica NP_001280847.1
pDHC13 MdENRL5 pEVE2177 yes Malus x domestica NP_001281005.1
pDHC14 MdHCDBR pEVE2177 yes Malus x domestica XP_008367739.1
pDHC15 ErERED pEVE2177 yes Eubacterium ramulus AGS82961.1
pDHC16 RiZS1 pEVE2177 yes Rubus idaeus AEL78825.1
pDHC17 PcCHS pEVE2176 yes Petroselinum crispum P16107.1
pDHC18 PhCHS pEVE2176 yes Petunia hybrida CAA32731.1
pDHC19 HvCHS1 pEVE2176 yes Hordeum vulgare P26018.1
pDHC20 HvCHS2 pEVE2176 yes Hordeum vulgare Q96562.1
pDHC21 SbCHS pEVE2176 yes Scutellaria baicalensis BAB03471.1
pDHC22 MdCHS1 pEVE2176 no Malus x domestica NP_001306186.1
pDHC23 MdCHS2 pEVE2176 no Malus x domestica NP_001306181.1
pDHC24 MdUGT88F1 pEVE2176 yes Malus x domestica D3UAG5.1
pDHC25 MdUGT88A1 pEVE2176 yes Malus x domestica B3TKC8.1
pDHC26 PcUGT88F2 pEVE2176 yes Pyrus communis D3UAG3.1
pDHC27 DcGT4 pEVE2176 yes Dianthus caryophyllus BAD52006.1
pDHC28 OsCGT pEVE2176 yes Oryza sativa subsp. japonica C3W7B0.1
pDHC29 AtUGT73B2 pEVE2178 yes Arabidopsis thaliana NP_567954.1
pDHC30 AtUGT76D1 pEVE2178 no Arabidopsis thaliana NP_180216.1
pDHC31 AtUGT84B1 pEVE2178 no Arabidopsis thaliana NP_179907.1
pDHC32 Cm1,2RHAT pEVE2179 yes Citrus maxima Q8GVE3.2
pDHC33 AtRHM2 pEVE2180 no Arabidopsis thaliana NP_564633.2
pDHC34 OsF3'H pEVE2177 yes Oryza sativa subsp. japonica XP_015613041.1
pDHC35 PhF3'H pEVE2177 yes Petunia hybrida Q9SBQ9.1
pDHC36 PfF3'H pEVE2177 yes Perilla frutescens var. crispa BAB59005.1
pDHC37 AcF3'H pEVE2177 yes Allium cepa AAS48419.1
pDHC38 MdF3'H1 pEVE2177 no Malus x domestica ACR14867.1
pDHC39 MdF3'H2 pEVE2177 no Malus x domestica XP_008374610.1
pDHC40 CsCH3H pEVE2177 yes Cosmos sulphureus ACO35755.1
pDHC41 AtATR1 pEVE2178 yes Arabidopsis thaliana NP_194183.1
pDHC42 CaER pEVE2177 yes Clostridium acetobutylicum WP_010966642.1
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analyzer was equipped with an electrospray source and operated in
negative mode. Capillary voltage was 3.0 kV; the source was kept at
150 °C and the desolvation temperature was 350 °C. Desolvation and
cone gas ﬂow were 500 l/h and 50 l/h, respectively. [M-H]− ions of
compounds of interest were tracked in SIR mode. Compounds were
quantiﬁed using a quadratic calibration curve with authentic standards
ranging from 0.156 mg/l to 80 mg/l for p-coumaric acid and phloretic
acid or from 0.039 mg/l to 20 mg/l for all other compounds.
3. Results and discussion
3.1. Testing DBRs for production of phloretin in metabolically
engineered yeast
Several previous studies focusing on heterologous production of
ﬂavonoids or stilbenoids in S. cerevisiae reported the appearance of
phloretic acid or phloretin as by-products and attributed this to an
unspeciﬁc activity of some native yeast DBR acting on p-coumarate or
p-coumaroyl-CoA to form phloretic acid or p-dihydrocoumaroyl-CoA,
respectively (Beekwilder et al., 2006; Jiang et al., 2005; Koopman et al.,
2012; Luque et al., 2014). By screening of 26 homozygous and
heterozygous deletion mutants of S. cerevisiae for genes that might
be involved in this DBR shunt activity, ScDFG10 and ScTSC13 were
identiﬁed as possible candidates (Lehka et al., submitted). ScDfg10 is a
polyprenol reductase involved in the biosynthesis of dolichol, the
precursor for protein N-glycosylation (Cantagrel et al., 2010).
ScTsc13 is a very long chain (VLC) enoyl-CoA reductase, catalysing
the double bond reduction in each cycle of VLC fatty acid elongation
(Kohlwein et al., 2001). These two enzymes were chosen for over-
expression in the attempt to construct a pathway to phloretin in S.
cerevisiae. In addition to the DBRs, the phloretin pathway comprised
the genes AtPAL2, AmC4H, ScCPR1, At4CL2, and HaCHS, which were
previously found to encode a functional naringenin pathway in yeast
(data not shown). Despite the absence of a chalcone isomerase (CHI),
naringenin production was expected in these strains, since the iso-
merization of naringenin chalcone to naringenin is known to happen
spontaneously (Mol et al., 1985). This spontaneous isomerization was
also observed for authentic standards of naringenin chalcone, so
naringenin was used for indirect quantiﬁcation of CHS products
derived from p-coumaroyl-CoA. Preliminary data suggested that over-
expression of ScTSC13 resulted in increased phloretin production
without aﬀecting ﬁnal cell density (Supplementary Fig. S1a).
Moreover, essentially no eﬀect was observed on the long chain and
VLC free fatty acid proﬁle (Supplementary Figs. S1b and S1c). This
suggested that overexpression of ScTSC13 alone has no impact on the
activity of the four-enzyme VLC fatty acid elongation machinery, which
additionally comprises ScELO2 or ScELO3, ScIFA38, and ScPHS1
(Dickson, 2008). Obviously, the DBR activity in the phloretin pathway
is not the native function of ScTsc13 and we wondered to what extent
this was a unique feature of this enzyme. We therefore tested four
homologous enzymes for this activity: KlTsc13 from Kluyveromyces
lactis was chosen as an example of a functionally similar enzyme from
another yeast. AtEcr from A. thaliana and GhEcr2 from cotton were
selected as they have previously been shown to complement S.
cerevisiae lacking ScTsc13 activity (Gable et al., 2004; Song et al.,
2009), thus conﬁrming that they can be functionally expressed in yeast.
Additionally, theM. x domesticaMdEcr homologue was selected due to
the high DHC content of this plant. On top of that, several recently
identiﬁed DBRs were tested for activity in our synthetic phloretin
pathway: three enzymes from apple were previously shown to be
implicated in DHC production, either by RNAi experiments
(MdEnrl3) or by in vitro reaction studies (MdEnrl5, MdHcdbr) (Dare
et al., 2013a; Ibdah et al., 2014). ErEred was selected because it has
been shown to produce phloretin from naringenin chalcone when
ErERED is expressed in anaerobically grown E. coli (Gall et al., 2014).
Finally, RiZs1 from raspberry was chosen because it reduces the double
bond of 4-hydroxybenzalacetone, which is structurally very similar to
p-coumaric acid (Koeduka et al., 2011). Twelve HRT plasmids were
constructed, co-expressing AtPAL2, AmC4H, ScCPR1, At4CL2, and
HaCHS together with either one of the eleven DBRs or a negative
control without DBR, to make the strains DBR1 to DBR12, and
production of naringenin and phloretin was quantiﬁed (Fig. 2).
Of the DBRs tested, only ScTsc13 and its close homologue KlTsc13
had any impact on the ratio of phloretin to naringenin. Strain DBR2,
overexpressing ScTSC13, was most eﬃcient in producing phloretin,
reaching a ﬁnal titer of 42.7 ± 0.9 mg/l and only 13.0 ± 0.6 mg/l of
naringenin. As mentioned above, ScTSC13 is an essential gene in S.
cerevisiae and the corresponding enzyme catalyses the double bond
reduction of VLC trans-2-enoyl-CoA (Kohlwein et al., 2001). Like the
native substrates of this enzyme, p-coumaroyl-CoA comprises an α,β-
unsaturated CoA thioester functional group. Therefore it seems likely
that p-coumaroyl-CoA is the actual substrate of the ScTsc13 side
activity.
During preparation of this manuscript, it was reported that a 2-
enoate reductase, CaEr, from Clostridium acetobutylicum was able to
reduce the double bond of cinnamic acid and p-coumaric acid when
expressed in E. coli (Sun et al., 2016). A phloretin pathway with this
DBR was therefore constructed on an HRT plasmid to create strain
DBR13 and production of phloretin and naringenin was compared to
strains DBR12 (control) and DBR2, overexpressing ScTSC13. The ratio
of phloretin to naringenin in DBR13 was in the same range as for the
control strain, indicating that CaEr is not active in the phloretin
pathway in yeast (Supplementary Fig. S2).
3.2. Characterization of the phloretin pathway in vivo
The overexpression of ScTSC13, together with a heterologous
pathway to naringenin chalcone, resulted in production of DHCs
instead of ﬂavonoids. In order to further elucidate the exact substrate
of ScTsc13 in this pathway, and to identify potential bottlenecks, six
truncated pathways were assembled on HRT plasmids to make strains
PAR1-PAR6 (Table 2). These strains were tested for production of
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cinnamic acid, p-coumaric acid, phloretic acid, naringenin, and phlor-
etin (Fig. 3). When the pathway was interrupted at the stage of p-
coumaric acid by leaving out At4CL2 and HaCHS (strains PAR5 and
PAR6) only p-coumaric acid was produced. No phloretic or cinnamic
acid was detected despite the overexpression of ScTSC13. This
suggested that AmC4h was not limiting in the pathway and that p-
coumaric acid was not a substrate of ScTsc13. When the pathway was
extended to include At4CL2 (strains PAR3 and PAR4) the yeast
produced only phloretic acid, whereas the p-coumaric acid concentra-
tion was below the detection limit. This suggested that At4cl2
eﬃciently activated p-coumaric acid to p-coumaroyl-CoA, which was
then reduced to p-dihydrocoumaroyl-CoA, even without overexpres-
sion of ScTSC13. p-Dihydrocoumaroyl-CoA was subsequently hydro-
lysed to phloretic acid, by an unspeciﬁc enzymatic reaction or
spontaneously. These results also showed that At4cl2 and ScTsc13
were not limiting under these experimental conditions.
Strains PAR1 and PAR2, comprising the full length pathway to
naringenin chalcone, both produced phloretin and naringenin. The
accumulation of both compounds most likely reﬂected the competition
between ScTsc13 and HaChs for p-coumaroyl-CoA. As expected, the
overexpression of ScTSC13 (PAR1) clearly shifted the balance of
production towards more phloretin and less naringenin compared to
PAR2. Both strains accumulated phloretic acid, suggesting slow con-
version of p-dihydrocoumaroyl-CoA to phloretin by HaChs, which
seemed to present a bottleneck in the current pathway. To conﬁrm
the gradual build-up of compounds measured after 72 h, we performed
a time course experiment using PAR1, analysing the accumulation of
relevant compounds (Supplementary Fig. S3). After a minor transient
accumulation of p-coumaric acid during the initial exponential growth
phase on glucose, there was a steady build-up of phloretic acid, as wells
as phloretin and naringenin, corresponding to a presumed slow
reaction of HaChs.
These results support the hypothesis that p-coumaroyl-CoA is a
substrate of ScTsc13 although we cannot completely exclude the
possibility that the enzyme has activity on naringenin chalcone.
However, this seems very unlikely, since naringenin chalcone does
not share any structural similarity, nor the CoA functional group, with
the natural substrates of the enzyme (Kohlwein et al., 2001).
Furthermore, naringenin chalcone quickly isomerizes to naringenin,
which does not contain the targeted double bond, and therefore is not a
substrate of ScTsc13. In fact, in the current pathway naringenin is an
unwanted by-product and, hence, a CHS that does not accept p-
coumaroyl CoA would be highly desirable. This would greatly simplify
balancing of the pathway, during further boosting and optimisation, as
there would be no competition with ScTsc13 for the same substrate.
While HaChs represents the major limiting step to be alleviated in the
heterologous pathway, another way to further increase phloretin
production would be to increase the ﬂux into the pathway, e.g. by
boosting phenylalanine production and increasing PAL activity. This
approach successfully increased production of naringenin (Koopman
et al., 2012), p-coumaric acid (Rodriguez et al., 2015), and resveratrol
(Li et al., 2015) in previous studies, which all share phenylalanine as
precursor.
3.3. Using ScTSC13 for production of pinocembrin DHC
While most DHCs found in nature are derived from phloretin, some
plants, such as Uvaria angolensis (Huﬀord and Oguntimein, 1980) or
Mitrella kentia (Benosman et al., 1997), accumulate also DHC
structures lacking the 4-hydroxy group. This means they are most
likely derived from pinocembrin DHC and are produced by CHS from
dihydrocinnamoyl-CoA and three units of malonyl-CoA. Hence, the
biosynthesis of these compounds would require a DBR acting on
cinnamoyl-CoA to form dihydrocinnamoyl-CoA (Fig. 4A). In order to
test whether ScTsc13 can also catalyse this reaction, two HRT plasmids
were constructed, creating strains PIN1 and PIN2, comprising the
pathway to pinocembrin chalcone (AtPAL2, At4CL2, and HaCHS)
either with or without additional overexpression of ScTSC13. These
strains were cultured and the production of pinocembrin and pino-
cembrin DHC was analysed (Fig. 4B). Strain PIN1, containing only the
Table 2
Genes on HRT plasmids in strains PAR1 to PAR6.
Strain Genes on corresponding HRT plasmid
PAR1 AtPAL2, AmC4H, ScCPR1, At4CL2, HaCHS, ScTSC13
PAR2 AtPAL2, AmC4H, ScCPR1, At4CL2, HaCHS
PAR3 AtPAL2, AmC4H, ScCPR1, At4CL2, ScTSC13
PAR4 AtPAL2, AmC4H, ScCPR1, At4CL2
PAR5 AtPAL2, AmC4H, ScCPR1, ScTSC13
PAR6 AtPAL2, AmC4H, ScCPR1
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Fig. 3. Production of phloretin (black), naringenin (grey), phloretic acid (white), and p-
coumaric acid (black hatching) by strains PAR1 to PAR6, containing an HRT plasmid
with partial and full phloretin pathways as shown in Table 2. Represented are average
and standard deviation of three independent cultures.
Fig. 4. (A) Biosynthetic route from cinnamic acid to pinocembrin and proposed route to
pinocembrin DHC. (B) Production of pinocembrin DHC (black) and pinocembrin (grey)
by strains PIN1 and PIN2, expressing a pathway to pinocembrin chalcone with AtPAL2,
At4CL2, and HaCHS either without (PIN1) or with (PIN2) overexpression of ScTSC13,
respectively. Represented are average and standard deviation of three independent
cultures. CHI, chalcone isomerase; CHS, chalcone synthase; DBR, double bond reduc-
tase; 4CL, 4-coumarate-CoA ligase.
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native expression of ScTSC13, produced 1.47 ± 0.07 mg/l of pinocem-
brin DHC in addition to 11.6 ± 0.3 mg/l of pinocembrin.
Overexpression of ScTSC13 in strain PIN2 increased the pinocembrin
DHC production to 2.6 ± 0.3 mg/l and decreased the pinocembrin
production to 0.43 ± 0.06 mg/l, demonstrating that ScTsc13 also
accepts cinnamoyl-CoA. Generally, production of pinocembrin and
pinocembrin DHC in strain PIN2 was lower than production of
naringenin and phloretin in strain DBR2, which might suggest that
At4cl2 and HaChs prefer the hydroxylated substrates, or that the
compounds lacking the 4-hydroxy group are more prone to degradation
in yeast.
3.4. Testing CHS from various plant species for more speciﬁc
phloretin production
The production of phloretin in strain DBR2 was unfortunately not
very speciﬁc with naringenin accumulating as a major by-product to
almost a third of the amount of phloretin produced (Fig. 2). In an
attempt to decrease this by-product formation, we tested a collection of
eight diﬀerent CHS enzymes from various plants for their ability to
produce naringenin or phloretin in yeast. Two of the CHS genes were
ampliﬁed from the peel ofM. x domestica var. Golden Delicious, as this
plant is known to accumulate high concentrations of DHCs (Dare et al.,
2013b; Gosch et al., 2009). Nine HRT plasmids containing the pathway
to p-dihydrocoumaroyl-CoA (AtPAL2, AmC4H, ScCPR1, At4CL2,
ScTSC13) together with one of the eight CHS, or no CHS as negative
control, were constructed to make strains CHS1 to CHS9 and the
production of naringenin and phloretin was quantiﬁed (Fig. 5). HaChs,
which was originally chosen for the highest eﬃciency in producing
naringenin in yeast (data not shown), was found to be the most eﬃcient
CHS for phloretin production as well. However, most speciﬁc for
phloretin production was strain CHS5 expressing HvCHS2. The
phloretin/naringenin ratio of this strain exceeded the ratio of strain
CHS1 expressingHaCHS by 17.2 ± 1.7 fold. This result was unexpected
because barley has not been reported to produce DHCs. In the original
publication describing HvChs2, an unusual substrate preference for
feruloyl-CoA and caﬀeoyl-CoA over p-coumaroyl-CoA and cinnamoyl-
CoA was reported, while p-dihydrocoumaroyl-CoA was not tested as
substrate. Furthermore, it was noted that the sequence of the enzyme
was unusually divergent from other CHS sequences (Christensen et al.,
1998). Hence, we did a multiple alignment (Supplementary Fig. S4) of
the chalcone synthases used in this study and the chalcone synthase
from Medicago sativa, for which the three dimensional structure was
determined (Ferrer et al., 1999). The alignment showed that HvChs2
contains two amino acid substitutions, T197A and F265I, at otherwise
highly conversed residues. According to the predicted structure, the
T197A substitution might aﬀect the interaction with the carbonyl group
of p-coumaroyl-CoA, whereas the F265I would aﬀect the separation of
the p-coumaroyl-binding pocket from the cyclisation pocket. (Ferrer
et al., 1999). Hence, these substitutions might provide some explana-
tion for this unusual preference of p-dihydrocoumaroyl-CoA over p-
coumaroyl-CoA. High substrate speciﬁcity may eventually be very
valuable, enabling a more streamlined downstream process, especially
in cases like this where product and by-product exhibit a high
structural similarity. The lower ﬁnal phloretin titer achieved in this
strain is an issue that most likely can be solved, e.g. by higher copy
numbers of HvCHS2. A similar strategy of using enzymes as ﬁlters for
selective production of the compound of interest was recently used in
E. coli for unnatural C50 carotenoids (Furubayashi et al., 2015).
3.5. Production of the monoglycosylated DHCs phlorizin and
nothofagin using known UGTs
In a next step, decorating enzymes were co-expressed in a strain
harbouring the phloretin pathway, to evaluate the feasibility and
versatility of such a strain as the basic production platform for various
DHCs. Strain DBR2 was used for these experiments, not only because it
produced more phloretin than strain CHS5, but also because the by-
product naringenin could be used as a positive control for functional
expression of decorating enzymes with activities on ﬂavanones. First, a
set of UGTs with reported activity on DHCs for production of phlorizin
(phloretin 2′-O-glucoside) (Gosch et al., 2010a; Jugdé et al., 2008;
Werner and Morgan, 2009) or nothofagin (phloretin 3′-C-glucoside)
(Brazier-Hicks et al., 2009) were tested. The corresponding genes were
expressed on a second HRT plasmid in strain DBR2, making strains
PHZ1 to PHZ4 and strain NOT1. Strain UGTn with an empty second
HRT plasmid was used as a negative control. The strains were cultured
and production of DHCs was measured. Of the four UGTs reported to
glycosylate phloretin to phlorizin, only MdUgt88a1 and PcUgt88f2
were eﬃciently catalysing this reaction in our yeast strain (Fig. 6A). On
the other hand, OsCgt was highly eﬃcient for nothofagin production,
converting phloretin almost completely to this C-glucoside (Fig. 6B).
3.6. Production of NDC using two substrate-promiscuous UGTs
Trilobatin, which is the 4′-O-glucoside of phloretin, is a DHC found
naturally in Malus trilobata and some other Malus species (Gosch
et al., 2010b; Martens, personal communication). It is an intermediate
in a proposed biosynthetic route to the sweetener NDC (Fig. 1B). The
equivalent position on the structurally related ﬂavonoids is the 7-
hydroxy group (Fig. 1A), and AtUgt73b2 has previously been described
as an enzyme with broad substrate ﬂexibility for diﬀerent ﬂavonoid
backbones (Willits et al., 2004). Two other enzymes, AtUgt84b1 and
AtUgt76d1, were shown to be speciﬁc for the 7-position of quercetin
(Lim et al., 2004). The three genes, encoding these enzymes, were
expressed on a second HRT plasmid in strain DBR2, to make strains
TRI1 to TRI3, and the production of DHCs was compared to the
negative control strain UGTn (Fig. 6C). Only AtUgt73b2 was able to
glycosylate phloretin to trilobatin. Besides producing 33 ± 3 mg/l of
trilobatin, it also exhibited minor 2′-O-glycosylation activity on phlor-
etin to produce 1.6 ± 0.21 mg/l of phlorizin. The next step in the
proposed route to NDC is the rhamnosylation of trilobatin with an α-
1,2 glycosidic bond. Cm1,2Rhat was reported to catalyse the corre-
sponding reaction on ﬂavanones to form naringin from naringenin 7-
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Fig. 5. Production of phloretin (black) and naringenin (grey) and the ratio of produced phloretin to naringenin (white) by strains CHS1 to CHS9, expressing a phloretin pathway with
AtPAL2, AmC4H, ScCPR1, At4CL2, and ScTSC13 with diﬀerent CHS (CHS1: HaCHS; CHS2: PcCHS; CHS3: PhCHS; CHS4: HvCHS1; CHS5: HvCHS2, CHS6: SbCHS; CHS7:MdCHS1;
CHS8: MdCHS2; CHS9: no CHS) on an HRT plasmid. Represented are average and standard deviation of three independent cultures.
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O-glucoside (Frydman et al., 2004). While UDP-rhamnose, the sugar
donor required by Cm1,2Rhat, is not naturally produced by S.
cerevisiae, its biosynthesis has been achieved by expression of
AtRHM2 from A. thaliana (Oka et al., 2007). Therefore, we expressed
AtUGT73B2, Cm1,2RHAT, and AtRHM2 on a second HRT plasmid in
strain DBR2 to make strain NDC1. By comparing the production of
DHCs in this strain to that of strain TRI3, which expressed only
AtUGT73B2, we could demonstrate the ability of Cm1,2Rhat to accept
trilobatin as substrate, allowing the production of 11.6 ± 0.7 mg/l of
NDC (Fig. 6D). A similar approach, using promiscuous enzymes, was
reported in E. coli, where substrate ﬂexibility of ﬂavanone 3β-hydro-
xylase (F3H), ﬂavonol synthase (FLS), and ﬂavonoid 3′-hydroxylase
(F3′H) was exploited for the assembly of a novel synthetic pathway for
the 5-deoxyﬂavonol ﬁsetin (Stahlhut et al., 2015). Here we adopted this
approach, showing that it can be more widely applied across biosyn-
thetic pathways. Interestingly, the enzymes which were eventually
selected for constructing the various pathways, all originate from
plants that have not been shown to produce DHCs.
3.7. Production of 3-hydroxyphloretin using a substrate promiscuous
CYP
Many DHCs, such as 3-hydroxyphlorizin, aspalathin, and neohe-
speridin DHC, contain a 3-hydroxy group (Fig. 1B). The speciﬁc
enzymes responsible for the biosynthesis of these compounds have
not been identiﬁed, although many F3′Hs and one CH3H enzyme have
been identiﬁed from various plants. These enzymes are regiospeciﬁc
cytochrome P450s (CYP), which can hydroxylate the equivalent posi-
tion in the structurally related ﬂavonoids and chalcones. As they are
CYPs, they require the action of a cytochrome P450 reductase (CPR) as
cofactor. A collection of six F3′H from various plants, plus CsCh3h,
were tested for their ability to form 3-hydroxyphloretin from phloretin
in yeast. Two of the F3′H were ampliﬁed from M. x domestica var.
Golden Delicious cDNA, with the rationale that they might be
promiscuous towards DHCs, since apple was reported to contain 3-
hydroxyphlorizin (Tsao et al., 2003). Eight HRT constructs containing
AtATR1 together with one of the seven CYPs, or no CYP as negative
control, were assembled in strain DBR2 to make strains HYP1 to HYP8
and production of DHCs was measured (Fig. 6E). While OsF3′h and
PhF3′h showed minor activity on phloretin, CsCh3h transformed more
than a third of the phloretin to 3-hydroxyphloretin. The apparent
inactivity of both apple F3′H proteins is in agreement with previous
experience with heterologous expression of F3′Hs from diﬀerentMalus
species, known to accumulate 3-hydroxylated DHCs, e.g. Malus
toringo syn sieboldii (Martens, unpublished). During preparation of
this manuscript another study was published, reporting the ability of
CsCh3h to accept phloretin as substrate, both in yeast and in plants.
Overexpression of CsCh3h in apple resulted in increased production of
3-hydroxyphlorizin, which correlated with reduced susceptibility to ﬁre
blight and scab (Hutabarat et al., 2016).
To summarize, the strain DBR2 was successfully used as a DHC
platform strain and the production of various derivatives of phloretin
was achieved by using decorating enzymes with known activities on
DHC or by exploiting substrate promiscuity of enzymes naturally
involved in ﬂavonoid or chalcone biosynthesis. Table 3 gives an
overview of the DHCs, for which de novo biosynthesis in S. cerevisiae
was demonstrated in this proof of concept study.
4. Conclusion
DHCs form a class of polyphenols comprising several molecules of
considerable commercial interest, e.g. as antioxidants, antidiabetics,
and sweeteners. Here we report the de novo production of a variety of
DHCs in a microbial host by expressing the full length biosynthetic
pathways, consisting of between four and nine genes (Table 3).
A critical step for the production of DHCs is the reduction of the
α,β-double bond of p-coumaroyl-CoA. We tested several previously
reported apple reductases, but were not able to show the desired
activity with any of these enzymes in yeast. Instead, we took advantage
of a side activity of the native yeast VLC enoyl-CoA-reductase ScTsc13,
normally involved in VLC fatty acid elongation. Upon overexpression,
this enzyme eﬃciently reduced the double bond of p-coumaroyl-CoA,
thus allowing the production of phloretin. The formation of naringenin,
a major by-product of the initial pathway, was then substantially
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Fig. 6. Engineering of strain DBR2 for production of various phloretin derivatives: (A) Production of phlorizin (white) and phloretin (black) by strains PHZ1 to PHZ4 and UGTn,
harbouring a second HRT plasmid, expressing diﬀerent UGTs or no UGT (PHZ1: MdUGT88F1; PHZ2: MdUGT88A1; PHZ3: PcUGT88F2; PHZ4: DcGT4; UGTn: no UGT). (B)
Production of nothofagin (white) and phloretin (black) by strains NOT1 and UGTn, harbouring a second HRT plasmid, expressing either OsCGT (NOT1) or no enzyme (UGTn). (C)
Production of trilobatin (white), phlorizin (grey), and phloretin (black) by strains TRI1 to TRI3 and UGTn, harbouring a second HRT plasmid, expressing diﬀerent UGTs or no UGT
(TRI1: AtUGT73B2; TRI2: AtUGT76D1; TRI3: AtUGT84B1; UGTn: no UGT). (D) Production of NDC (white), trilobatin (grey), and phloretin (black) by strains NDC1 and TRI1,
harbouring a second HRT plasmid, expressing either AtUGT73B2, Cm1,2RHAT, and AtRHM2 (NDC1) or only AtUGT73B2 (TRI1). (E) Production of 3-hydroxyphloretin (white) and
phloretin (black) by strains HYP1 to HYP8, harbouring a second HRT plasmid, expressing diﬀerent CYPs or no CYP together with AtATR1 (HYP1: OsF3′H; HYP2: PhF3′H; HYP3:
PfF3′H; HYP4: AcF3′H; HYP5: MdF3′H1; HYP6: MdF3′H2; HYP7: CsCH3H; HYP8: no enzyme). Represented are average and standard deviation of three independent cultures.
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reduced by using a highly speciﬁc barley CHS in the last step of the
pathway. Conversely, two non-speciﬁc enzymes were employed for
assembling the pathways to trilobatin and NDC. We showed that the
ﬁnal glycosylation to these compounds could be performed by UGTs
normally involved in the modiﬁcation of ﬂavonoids.
While the heterologous production of DHCs in this study was
reasonably high, a signiﬁcant increase would be necessary for an
economically feasible industrial production process. Two recent studies
on metabolic engineering of p-coumaric acid (Rodriguez et al., 2015)
and resveratrol (Li et al., 2015) in S. cerevisiae showed that increasing
the pool of aromatic amino acids and cytoplasmic malonyl-CoA,
increasing the copy number of rate limiting pathway enzymes, and
performing a controlled fed batch fermentation resulted in a substan-
tial increase of product titers, reaching 1.93 g/l for p-coumaric acid and
531.41 mg/l for resveratrol. As the precursors of those compounds are
shared with DHCs, similar approaches should be applicable for
increasing the titers of commercially relevant DHCs.
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